Literature DB >> 8899381

Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion.

I J Spijkerman1, M W Langendam, P J Veugelers, E J van Ameijden, I P Keet, R B Geskus, A van den Hoek, R A Coutinho.   

Abstract

We compared rates of progression to AIDS for 99 injection drug users and 120 homosexual men with documented dates of HIV-1 seroconversion. The crude risk of developing AIDS was higher among homosexual men than injection drug users [relative hazard (RH) = 2.4; 95% confidence interval (CI) = 1.3-4.4]. The relative hazard was slightly smaller among participants with a seroconversion interval of < or = 1 year (RH = 2.2; 95% CI = 1.0-5.2). The effect was partially explained by the inclusion of Kaposi's sarcoma in the AIDS case definition. Excluding those with Kaposi's sarcoma, the relative hazard was 2.0 (95% CI = 1.1-3.8). Using the 1993 AIDS case definition decreased the effect (RH = 1.9; 95% CI = 1.1-3.4). Finally, the high pre-AIDS mortality among injection drug users could partially explain the difference in progression rate between injection drug users and homosexual men. Combining the effect of the above-mentioned factors resulted in a relative hazard of 1.3 (95% CI = 0.7-2.6). Thus, the slower progression to AIDS among injection drug users compared with homosexual men was largely explained by differences in the spectrum of AIDS-defining illnesses, pre-AIDS mortality, and length of seroconversion interval.

Entities:  

Mesh:

Year:  1996        PMID: 8899381     DOI: 10.1097/00001648-199611000-00002

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  9 in total

1.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

2.  Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362.

Authors:  Susan E Cohn; Hongyu Jiang; J Allen McCutchan; Susan L Koletar; Robert L Murphy; Kevin R Robertson; Annabelle M de St Maurice; Judith S Currier; Paige L Williams
Journal:  AIDS Care       Date:  2011-06

3.  Morphine potentiates neuropathogenesis of SIV infection in rhesus macaques.

Authors:  Sirosh M Bokhari; Ramakrishna Hegde; Shannon Callen; Honghong Yao; Istvan Adany; Qingsheng Li; Zhuang Li; David Pinson; Hung-Wen Yeh; Paul D Cheney; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-24       Impact factor: 4.147

4.  Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men.

Authors:  C M Lyles; N M Graham; J Astemborski; D Vlahov; J B Margolick; A J Saah; H Farzadegan
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

5.  Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials.

Authors:  Mariam Riazi; Joanne K Marcario; Frank K Samson; Himanshu Kenjale; Istvan Adany; Vincent Staggs; Emily Ledford; Janet Marquis; Opendra Narayan; Paul D Cheney
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-13       Impact factor: 4.147

6.  Methods for estimating HIV prevalence: A comparison of extrapolation from surveys on infection rate and risk behaviour with back-calculation for the Netherlands.

Authors:  H Houweling; S H Heisterkamp; L G Wiessing; R A Coutinho; J K van Wijngaarden; H J Jager
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

7.  Comparison of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups.

Authors:  C M Lyles; D Vlahov; H Farzadegan; J Astemborski; J B Margolick; B A Masters; J Schroeder; T C Quinn
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

8.  Rapid dissemination of SIV follows multisite entry after rectal inoculation.

Authors:  Patricia Ribeiro Dos Santos; Magali Rancez; Jean-Luc Prétet; Alice Michel-Salzat; Valérie Messent; Anna Bogdanova; Anne Couëdel-Courteille; Evelyne Souil; Rémi Cheynier; Cécile Butor
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

9.  The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts.

Authors:  Johannes Prottengeier; Eleni Koutsilieri; Carsten Scheller
Journal:  AIDS Res Ther       Date:  2014-07-02       Impact factor: 2.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.